Advertisement

Urolithiasis

, Volume 46, Issue 6, pp 535–541 | Cite as

Three-dimensional evaluation of perirenal fat volume in patients with nephrolithiasis

  • Daniel J. Lama
  • Shoaib Safiullah
  • Albert Yang
  • Zhamshid Okhunov
  • Jaime Landman
  • Ralph V. Clayman
Original Paper
  • 107 Downloads

Abstract

The concept of adipose tissue as an organ unto itself represents a new medical construct; already differences in the volume of perirenal fat around a tumor-bearing kidney have been described. We hypothesized that renal calculi may have similar impact on perirenal fat or alternatively abnormalities in urinary metabolites may be the result of perirenal fat affecting renal metabolism and subsequent stone formation. Accordingly, we conducted a study utilizing three-dimensional imaging software to evaluate perirenal fat volume (PFV) in patients with nephrolithiasis. Among 40 patients with a history of unilateral nephrolithiasis who underwent percutaneous nephrolithotomy between 2010 and 2016, the following data were acquired: body mass index, past medical history, stone characteristics and composition (i.e., calcium oxalate, calcium phosphate, uric acid, and struvite calculi). In addition, patients were stratified by dominant stone composition (≥ 50% fraction). Bilateral PFV measurements were obtained using the preoperative computed tomography scan and specialized three-dimensional imaging software. The PFV of stone-bearing kidneys was significantly greater than non-stone-bearing kidneys (397.3 and 323 cc, respectively; p = 0.004), with the PFV difference in patients with CO-dominant stone-bearing kidneys reaching statistical significance (p = 0.003). Subgroup analysis showed greater PFV surrounding the stone-bearing kidney irrespective of gender (p = 0.03), with male patients possessing significantly greater stone-bearing (p = 0.01) and bilateral PFV (p = 0.01) compared to females. No significant correlations were found between PFV and stone volume or stone density. The PFV of calcium oxalate stone-bearing kidneys is significantly greater than non-stone-bearing kidneys for both male and female patients with nephrolithiasis.

Keywords

Nephrolithiasis Obesity Percutaneous nephrolithotomy Perirenal fat Visceral fat Adipose tissue 

Abbreviations

BMI

Body mass index

CO

Calcium oxalate

CP

Calcium phosphate

CT

Computed tomography

DM

Diabetes mellitus

HU

Hounsfield units

HTN

Hypertension

UA

Uric acid

PCNL

Percutaneous nephrolithotomy

PFV

Perirenal fat volume

Notes

Acknowledgements

We would like to thank the following personnel for their contribution to the manuscript. Data collection: Anastasia Cruz MD, Mitchell Daun MD, and Adam Rudd MD. Data analysis: Tuyen Hoang PhD.

Funding

None.

Compliance with ethical standards

Conflict of interest

Daniel J. Lama declares that he has no conflict of interest. Shoaib Safiullah declares that he has no conflict of interest. Albert Yang declares that he has no conflict of interest. Zhamshid Okhunov declares that he has no conflicts of interest. Jaime Landman declares that he has no conflict of interest. Ralph V. Clayman declares that he has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462CrossRefGoogle Scholar
  2. 2.
    Ogden CL, Carroll MD, Fryar CD, Flegal KM (2015) Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief 219:1–8Google Scholar
  3. 3.
    Scales CD Jr, Smith AC, Hanley JM, Saigal CS (2012) Urologic diseases in America. Prevalence of kidney stones in the United States. Eur Urol 62:160–165CrossRefGoogle Scholar
  4. 4.
    Eisner BH, Porten SP, Bechis SK, Stoller ML (2010) Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol 183:2244–2248CrossRefGoogle Scholar
  5. 5.
    Tran TY, Flynn M, O’Bell J, Pareek G (2016) Calculated insulin resistance correlates with stone-forming urinary metabolic changes and greater stone burden in high-risk stone patients. Clin Nephrol 85:316–320CrossRefGoogle Scholar
  6. 6.
    DiBianco JM, Jarrett TW, Mufarrij P (2015) Metabolic syndrome and nephrolithiasis risk: should the medical management of nephrolithiasis include the treatment of metabolic syndrome? Rev Urol 17:117–128PubMedPubMedCentralGoogle Scholar
  7. 7.
    Wong Y, Cook P, Roderick P, Somani BK (2016) Metabolic syndrome and kidney stone disease: a systematic review of literature. J Endourol 30:246–253CrossRefGoogle Scholar
  8. 8.
    Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652PubMedGoogle Scholar
  9. 9.
    Fox CS, Larson MG, Leip EP, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291:844–850CrossRefGoogle Scholar
  10. 10.
    von Hafe P, Pina F, Perez A, Tavares M, Barros H (2004) Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 12:1930–1935CrossRefGoogle Scholar
  11. 11.
    Okhunov Z, Mues AC, Kline M, Haramis G, Xu B, Mirabile G, Vira M, Landman J (2012) Evaluation of perirenal fat as a predictor of cT1a renal cortical neoplasm histopathology and surgical outcomes. J Endourol 26:911–916CrossRefGoogle Scholar
  12. 12.
    Türk C, Knoll T, Petrik A, Sarcia K, Skolarikos A, Straub M, Seitz C (2015) Guidelines on urolithiasis. European Association of Urology. http://uroweb.org/wp-content/uploads/22-Urolithiasis_LR_full.pdf. Accessed 19 June 2017
  13. 13.
    Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16:2134–2140CrossRefGoogle Scholar
  14. 14.
    Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, Nicklas B, Hamilton C, Hundley WG (2010) Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension 56:901–906CrossRefGoogle Scholar
  15. 15.
    Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS (2011) Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension 58:784–790CrossRefGoogle Scholar
  16. 16.
    Stolarczyk J, Carone FA (1975) Effects of renal lymphatic occlusion and venous constriction on renal function. Am J Pathol 78:285–296PubMedPubMedCentralGoogle Scholar
  17. 17.
    Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG (2004) Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord 28:S58-65CrossRefGoogle Scholar
  18. 18.
    Ma S, Zhu XY, Eirin A, Woollard JR, Jordan KL, Tang H, Lerman A, Lerman LO (2016) Perirenal fat promotes renal arterial endothelial dysfunction in obese swine through tumor necrosis factor-alpha. J Urol 195:1152–1159CrossRefGoogle Scholar
  19. 19.
    Hou N, Han F, Wang M, Huang N, Zhao J, Liu X, Sun X (2014) Perirenal fat associated with microalbuminuria in obese rats. Int Urol Nephrol 46:839–845CrossRefGoogle Scholar
  20. 20.
    Pragasam V, Sakthivel R, Kalaiselvi P, Rajesh NG, Varalakshmi P (2005) Detection of endothelial nitric oxide synthase and NADPH-diaphorase in experimentally induced hyperoxaluric animals. Urol Res 33:301–308CrossRefGoogle Scholar
  21. 21.
    Bagga HS, Chi T, Miller J, Stoller ML (2013) New insights into the pathogenesis of renal calculi. Urol Clin North Am 40:1–12CrossRefGoogle Scholar
  22. 22.
    Jang S, Lee CH, Choi KM, Lee J, Choi JW, Kim KA, Park CM (2011) Correlation of fatty liver and abdominal fat distribution using a simple fat computed tomography protocol. World J Gastroenterol 17:3335–3341CrossRefGoogle Scholar
  23. 23.
    Shuster A, Patlas M, Pinthus JH, Mourtzakis M (2012) The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 85:1–10CrossRefGoogle Scholar
  24. 24.
    Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Varsan RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RB Sr., Donnell CJ (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116:39–48CrossRefGoogle Scholar
  25. 25.
    Simpson JA, MacInnis RJ, Peeters A, Hopper JL, Giles GG, English DR (2007) A comparison of adiposity measures as predictors of all-cause mortality: the Melbourne Collaborative Cohort Study. Obesity 15:994–1003CrossRefGoogle Scholar
  26. 26.
    Favre G, Grangeon-Chapon C, Raffaelli C, Francois-Chalmin F, Ianelli A, Esnault V (2017) Perirenal fat thickness measured with computed tomography is a reliable estimate of perirenal fat mass. PLoS One 12:e0175561CrossRefGoogle Scholar
  27. 27.
    Grauer WO, Moss AA, Cann CE, Goldberg HI (1984) Quantification of body fat distribution in the abdomen using computed tomography. Am J Clin Nutr 39:631–637CrossRefGoogle Scholar
  28. 28.
    Heaton JM (1972) The distribution of brown adipose tissue in the human. J Anat 112:35–39PubMedPubMedCentralGoogle Scholar
  29. 29.
    Baba S, Jacene HA, Engles JM, Hond H, Wahl RL (2010) CT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studies. J Nucl Med 51:246–250CrossRefGoogle Scholar
  30. 30.
    Thamilselvan S, Khan SR, Menon M (2003) Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31:3–9PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Daniel J. Lama
    • 1
  • Shoaib Safiullah
    • 1
  • Albert Yang
    • 2
  • Zhamshid Okhunov
    • 1
  • Jaime Landman
    • 1
  • Ralph V. Clayman
    • 1
  1. 1.Department of Urology, Irvine (UCI) School of MedicineUniversity of CaliforniaIrvineUSA
  2. 2.Department of Radiology, School of MedicineUniversity of CaliforniaIrvineUSA

Personalised recommendations